<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biol Chem</journal-id><journal-id journal-id-type="iso-abbrev">J. Biol. Chem</journal-id><journal-id journal-id-type="publisher-id">jbc</journal-id><journal-title-group><journal-title>The Journal of Biological Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0021-9258</issn><issn pub-type="epub">1083-351X</issn><publisher><publisher-name>American Society for Biochemistry and Molecular Biology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19004826</article-id><article-id pub-id-type="pmc">2631958</article-id><article-id pub-id-type="publisher-id">3219</article-id><article-id pub-id-type="doi">10.1074/jbc.M805963200</article-id><article-categories><subj-group subj-group-type="heading"><subject>Protein Structure and Folding</subject></subj-group></article-categories><title-group><article-title>Control of Periplasmic Interdomain Thiol:Disulfide Exchange in theTransmembrane OxidoreductaseDsbD<xref ref-type="fn" rid="fn1">*</xref><xref ref-type="fn" rid="fn3">&#x00053;&#x020de;</xref></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mavridou</surname><given-names>Despoina A. I.</given-names></name><xref ref-type="aff" rid="d32e119">&#x02021;</xref><xref ref-type="fn" rid="fn4">1</xref><xref ref-type="fn" rid="fn5">2</xref></contrib><contrib contrib-type="author"><name><surname>Stevens</surname><given-names>Julie M.</given-names></name><xref ref-type="aff" rid="d32e119">&#x02021;</xref><xref ref-type="fn" rid="fn4">1</xref><xref ref-type="fn" rid="fn6">3</xref></contrib><contrib contrib-type="author"><name><surname>Goddard</surname><given-names>Alan D.</given-names></name><xref ref-type="aff" rid="d32e119">&#x02021;</xref><xref ref-type="fn" rid="fn6">3</xref></contrib><contrib contrib-type="author"><name><surname>Willis</surname><given-names>Antony C.</given-names></name><xref ref-type="aff" rid="d32e119">&#x000a7;</xref></contrib><contrib contrib-type="author"><name><surname>Ferguson</surname><given-names>Stuart J.</given-names></name><xref ref-type="aff" rid="d32e119">&#x02021;</xref><xref ref-type="fn" rid="fn6">3</xref><xref ref-type="corresp" rid="cor1">4</xref></contrib><contrib contrib-type="author"><name><surname>Redfield</surname><given-names>Christina</given-names></name><xref ref-type="aff" rid="d32e119">&#x02021;</xref><xref ref-type="corresp" rid="cor2">5</xref></contrib></contrib-group><aff id="d32e119"><label><sup>&#x02021;</sup></label>Department of Biochemistry and<label><sup>&#x000a7;</sup></label>Medical Research CouncilImmunochemistry Unit, University of Oxford, South Parks Road, Oxford OX1 3QU,United Kingdom</aff><author-notes><corresp id="cor1"><label>4</label>To whom correspondence may be addressed. Tel.: 44-1865-613200; Fax:44-1865-613201; E-mail:<email>stuart.ferguson@bioch.ox.ac.uk</email>.</corresp><corresp id="cor2"><label>5</label>Recipient of Wellcome Trust Grant 079440. To whom correspondence may beaddressed. Tel.: 44-1865-613200; Fax: 44-1865-613201; E-mail:<email>christina.redfield@bioch.ox.ac.uk</email>.</corresp><fn id="fn4"><label>1</label><p>Both authors contributed equally to this work.</p></fn><fn id="fn5"><label>2</label><p>Recipient of funding from the <funding-source>BodossakiFoundation</funding-source> and the <funding-source>Alexander S. Onassis PublicBenefit Foundation</funding-source>.</p></fn><fn id="fn6"><label>3</label><p>Recipient of <funding-source>Biotechnology and Biological Sciences ResearchCouncil</funding-source> Grants <award-id>BBE0048651</award-id> (to J.M.S.and S.J.F.) and <award-id>BBD5230191</award-id> (to A.D.G. and S.J.F.).</p></fn></author-notes><pub-date pub-type="ppub"><day>30</day><month>1</month><year>2009</year></pub-date><pub-date pub-type="pmc-release"><day>30</day><month>1</month><year>2009</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on 			/art/copyright. --><volume>284</volume><issue>5</issue><fpage>3219</fpage><lpage>3226</lpage><history><date date-type="received"><day>1</day><month>8</month><year>2008</year></date><date date-type="rev-recd"><day>10</day><month>11</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009, The American Society for Biochemistry andMolecular Biology, Inc.</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access"><license-p><italic>Author's Choice</italic></license-p><license-p><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">CreativeCommons Attribution Non-Commercial License</ext-link> applies to AuthorChoice Articles</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="zbc00509003219.pdf"/><abstract><p>The bacterial protein DsbD transfers reductant from the cytoplasm to theotherwise oxidizing environment of the periplasm. This reducing power isrequired for several essential pathways, including disulfide bond formationand cytochrome <italic>c</italic> maturation. DsbD includes a transmembrane domain(tmDsbD) flanked by two globular periplasmic domains (nDsbD/cDsbD); eachcontains a cysteine pair involved in electron transfer via a disulfideexchange cascade. The final step in the cascade involves reduction of theCys<sup>103</sup>-Cys<sup>109</sup> disulfide of nDsbD by Cys<sup>461</sup> ofcDsbD. Here we show that a complex between the globular periplasmic domains istrapped <italic>in vivo</italic> only when both are linked by tmDsbD. We have foundpreviously (<mixed-citation publication-type="journal" id="d32e215">Mavridou, D. A., Stevens, J. M., Ferguson, S. J.,&#x00026; Redfield, C. (<year>2007</year>) <source>J. Mol. Biol.</source><volume>370</volume>,<fpage>643</fpage>-658<pub-id pub-id-type="pmid">17544440</pub-id></mixed-citation>) that the attackingcysteine (Cys<sup>461</sup>) in isolated cDsbD has a highp<italic>K<sub>a</sub></italic> value (10.5) that makes this thiol relativelyunreactive toward the target disulfide in nDsbD. Here we show using NMR thatactive-site p<italic>K<sub>a</sub></italic> values change significantly when cDsbDforms a complex with nDsbD. This modulation of p<italic>K<sub>a</sub></italic> valuesis critical for the specificity and function of cDsbD. Uncomplexed cDsbD is apoor nucleophile, allowing it to avoid nonspecific reoxidation; however, incomplex with nDsbD, the nucleophilicity of cDsbD increases permittingreductant transfer. The observation of significant changes in active-sitep<italic>K<sub>a</sub></italic> values upon complex formation has wider implicationsfor understanding reactivity in thiol:disulfide oxidoreductases.</p></abstract></article-meta><notes><fn-group><fn id="fn1"><label>*</label><p>The costs of publication of this article were defrayed in part by thepayment of page charges. This article must therefore be hereby marked&#x0201c;<italic>advertisement</italic>&#x0201d; in accordance with 18 U.S.C. Section 1734solely to indicate this fact.</p></fn><fn id="fn3"><label/><p>The on-line version of this article (available at<ext-link ext-link-type="uri" xlink:href="http://www.jbc.org">http://www.jbc.org</ext-link>)contains supplemental Experimental Procedures, Figs. S1 and S2, Tables S1 andS2, and additional references.</p></fn><fn id="fn2"><label/><p><italic>Author's Choice</italic>&#x02014;Final version fullaccess.</p></fn></fn-group></notes></front><body><p>DsbD is a unique protein that transfers reductant across the cytoplasmicmembrane to the periplasm in many Gram-negative bacteria(<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>). Provision of reductant tothe periplasm is required because this compartment is otherwise considered tobe an oxidizing environment(<xref ref-type="bibr" rid="ref2">2</xref>). DsbD includes threedomains, each containing a pair of cysteine residues that perform a series ofdisulfide exchange reactions (<xref ref-type="fig" rid="fig1">Fig.1<italic>A</italic></xref>). In the first step, the transmembrane domain (tmDsbD)accepts electrons from thioredoxin in the cytoplasm; these are thentransferred to the periplasmic C-terminal domain (cDsbD) and finally to theN-terminal domain (nDsbD), which is also located in the periplasm(<xref ref-type="bibr" rid="ref3">3</xref>-<xref ref-type="bibr" rid="ref5">5</xref>).nDsbD acts as a junction point for several pathways that require reductant,including the general disulfide isomerase system and the pathway that isthought to reduce the cysteine thiols of apocytochromes in the cytochrome<italic>c</italic> biogenesis pathway(<xref ref-type="bibr" rid="ref6">6</xref>). In Gram-positive bacteria,CcdA, an integral membrane protein, and ResA, which has a thioredoxin fold,provide the reductant required for cytochrome <italic>c</italic> maturation(<xref ref-type="bibr" rid="ref7">7</xref>).</p><p>Structural studies have sought to explain how DsbD functions and interactswith its various partners. The structures of the two soluble periplasmicdomains have been determined (<xref ref-type="fig" rid="fig1">Fig.1<italic>A</italic></xref>, <italic>left</italic>). nDsbD has an immunoglobulin-likestructure (<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref9">9</xref>) and is the only knownthiol:disulfide oxidoreductase with this fold. cDsbD has the more typicalthioredoxin fold found in many oxidoreductases; this has the characteristicactive-site C<italic>XX</italic>C motif(<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref11">11</xref>). A covalent complexbetween single-cysteine variants of each of these two domains was produced<italic>in vitro</italic> and its x-ray structure solved(<xref ref-type="bibr" rid="ref12">12</xref>), revealing the interfacebetween the two domains (<xref ref-type="fig" rid="fig1">Fig.1<italic>A</italic></xref>, <italic>right</italic>). Although this mixed disulfide isaccepted as a physiological intermediate in the function of DsbD, an <italic>invivo</italic> complex between the two soluble domains has not been reportedpreviously (<xref ref-type="bibr" rid="ref3">3</xref>). Furthercomplexes between nDsbD and its other physiological partners have also beentrapped and their structures examined(<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref13">13</xref>). Interestingly, all of theinteraction partners of nDsbD are thioredoxin-like proteins; similarities intheir folds are congruous with common interaction interfaces(<xref ref-type="bibr" rid="ref14">14</xref>). However, only cDsbD willreduce nDsbD, whereas nDsbD will reduce several partners. This raisesquestions about how the direction of reductant flow is maintained andcontrolled within the series of disulfide-exchange reactions.</p><p>As part of our structural and mechanistic characterization of DsbD and itsdomains in solution, we have previously measured by NMR thep<italic>K<sub>a</sub></italic> values of the active-site cysteine pair,Cys<sup>461</sup> and Cys<sup>464</sup>, of cDsbD (numbered according to thefull-length <italic>Escherichia coli</italic> DsbD sequence)(<xref ref-type="bibr" rid="ref15">15</xref>). An unusually highp<italic>K<sub>a</sub></italic> value of 10.5 was measured for the N-terminal cysteineof the C<italic>XX</italic>C motif, Cys<sup>461</sup>, and the p<italic>K<sub>a</sub></italic>value of the second cysteine, Cys<sup>464</sup>, was significantly higher thanthe maximum pH value that was studied (pH 12.2). The p<italic>K<sub>a</sub></italic>value of 10.5 is the highest reported for the N-terminal cysteine of theC<italic>XX</italic>C motif in a thioredoxin fold. The striking consequence of theelevated p<italic>K<sub>a</sub></italic> value is that the active-site cysteine ofcDsbD, Cys<sup>461</sup>, is not strongly nucleophilic, raising criticalquestions about how this cysteine reacts with the disulfide in nDsbD. It wasdemonstrated using site-directed mutagenesis that the negatively charged sidechains of Asp<sup>455</sup> and Glu<sup>468</sup>, which are located close tothe C<italic>XX</italic>C motif (<xref ref-type="fig" rid="fig1">Fig.1<italic>B</italic></xref>), are responsible for the unusually highp<italic>K<sub>a</sub></italic> value of Cys<sup>461</sup>; mutation of one or both ofthese residues to Asn and Gln, respectively, resulted in decreases in thep<italic>K<sub>a</sub></italic> value of Cys<sup>461</sup> from 10.5 to 9.9 (E468Q),to 9.3 (D455N), and to 8.6 (D455N/E468Q). The p<italic>K<sub>a</sub></italic> valuesfor Asp<sup>455</sup> were found to be 5.9 and 6.6 in oxidized and reducedcDsbD; these values are significantly higher than the value of &#x0223c;4 for anunperturbed aspartic acid. We postulated that the properties of the amino acidside chains in the immediate environment of the cysteines in cDsbD wouldchange upon complex formation with nDsbD, changing the reactivity of thecysteines and explaining how the reaction between the two domains is initiated(<xref ref-type="bibr" rid="ref15">15</xref>). Specifically, weproposed that an increase in the p<italic>K<sub>a</sub></italic> value ofAsp<sup>455</sup> upon complex formation would lead to a decrease in thep<italic>K<sub>a</sub></italic> value of Cys<sup>461</sup>, thereby making it a betternucleophile. Stirnimann <italic>et al.</italic>(<xref ref-type="bibr" rid="ref10">10</xref>) previously presentedp<italic>K<sub>a</sub></italic> calculations suggesting an increase in theAsp<sup>455</sup> p<italic>K<sub>a</sub></italic> value upon complex formation.</p><p><fig position="float" id="fig1"><label>FIGURE 1.</label><caption><p><bold>Schematic representation of DsbD.</bold><italic>A,</italic> proposed pathway ofelectron flow from thioredoxin (<italic>TrxA</italic>) in the cytoplasm, via the threedomains of DsbD, to the cytochrome <italic>c</italic> maturation (<italic>Ccm</italic>) anddisulfide bond isomerization pathways in the periplasm is shown. The crystalstructure of nDsbD is from Protein Data Bank code 1L6P(<xref ref-type="bibr" rid="ref8">8</xref>), cDsbD from Protein DataBank code 1UC7 (<xref ref-type="bibr" rid="ref11">11</xref>), and thenDsbD-cDsbD complex from Protein Data Bank code 1VRS(<xref ref-type="bibr" rid="ref12">12</xref>). The <italic>cyan boxes</italic>indicate the thrombin cleavage sites introduced into full-length DsbD to allowdetection of the nDsbD-cDsbD complex following its formation <italic>in vivo</italic>.The cysteine residues are shown in <italic>yellow. B,</italic> schematicrepresentation of the active site of cDsbD in the covalent complex with nDsbD(<xref ref-type="bibr" rid="ref12">12</xref>). Some active-siteresidues of cDsbD are indicated in <italic>stick representation</italic> and theinter-domain disulfide (Cys<sup>461</sup>-SS-Cys<sup>109</sup>) is shown in<italic>yellow</italic>.</p></caption><graphic xlink:href="zbc0060963300001"/></fig></p><p>The aim of this work has been to determine the molecular basis of thecontrol of the reactivity of the active-site cysteine residues in cDsbD, usingNMR to compare the active-site properties of cDsbD alone and in itsphysiological complex with nDsbD. We demonstrate that thep<italic>K<sub>a</sub></italic> value of Asp<sup>455</sup> is elevated by at least 1.1pH units when cDsbD forms a complex with nDsbD. This modulation of thep<italic>K<sub>a</sub></italic> value is critical for the specificity and function ofcDsbD. These <italic>in vitro</italic> studies are complemented by <italic>in vivo</italic>studies on complex formation, in which we have trapped the nDsbD-cDsbD complexfor the first time. The results of our experiments explain how theintramolecular disulfide cascade within the soluble domains of DsbD functions,and demonstrate the importance of the transmembrane domain in controlling andfacilitating complex formation between the soluble domains.</p><sec sec-type="methods"><title>EXPERIMENTAL PROCEDURES</title><p><italic>Construction of DsbD Plasmids</italic>&#x02014;The plasmid pDzc1 was used toexpress isolated wild-type cDsbD bearing a C-terminal His<sub>6</sub> tag andthe plasmid pDzc5 a single cysteine variant (C464A) of cDsbD with a thrombincleavage site preceding the C-terminal His<sub>6</sub> tag. Isolated nDsbDwith the PelB signal peptide replacing the endogenous signal peptide and witha C-terminal streptavidin tag was expressed from the plasmid pDzn1, and fromthat a single-cysteine variant (C103A) was produced. Finally, the full-lengthconstruct in which nDsbD and cDsbD could be cleaved from tmDsbD(thrombin-cleavable DsbD) was expressed from pDsbd4. Details of the productionof the above plasmids can be found in supplemental material.</p><p><italic>Protein Production, Purification, and Characterization</italic>&#x02014;Allexperiments were performed in the <italic>E. coli</italic> strain BL21(DE3)(Stratagene). All cells expressing unlabeled protein were grown at 37 &#x000b0;Cin 500-ml volumes of Luria Bertani (LB) broth in 2-liter flasks from overnightstarter cultures (grown at 37 &#x000b0;C). SDS-PAGE analysis was carried out on10-20% BisTris<xref ref-type="fn" rid="fn7">6</xref> NuPAGEgels (Invitrogen) with prestained protein markers (SeeBlue Plus 2,Invitrogen).</p><p><italic>Overexpression of Thrombin-cleavable DsbD</italic>&#x02014;Bacteriatransformed with pDsbd4 were grown with 100 &#x003bc;g ml<sup>-1</sup>carbenicillin to an <italic>A</italic><sub>600</sub> of 0.7 before addition of 0.5m<sc>m</sc> isopropyl &#x003b2;-<sc>d</sc>-thiogalactopyranoside. Afterfurther incubation for 3 h the cells were harvested, and the crude membranefraction was isolated using a French press. Disruption of the cells wasperformed at 16,000 p.s.i. which was followed by centrifugation at 257,000&#x000d7; <italic>g</italic> for 1.5 h at 4 &#x000b0;C. The membrane fraction wassolubilized at a protein concentration of 5 mg ml<sup>-1</sup> for 1 h at 4&#x000b0;C under gentle agitation in 20 m<sc>m</sc> Tris-HCl, 300 m<sc>m</sc>NaCl, 20% v/v glycerol, 1% w/v <italic>n</italic>-dodecyl&#x003b2;-<sc>d</sc>-maltoside (DDM) (Anatrace) (pH 7.5). Unsolubilizedmaterial was removed by centrifugation at 257,000 &#x000d7; <italic>g</italic> for 45min at 4 &#x000b0;C. The supernatant was applied to 10 ml of Fast FlowChelating-Sepharose (Amersham Biosciences) charged with Ni<sup>2+</sup>. Thecolumn was washed with 20 m<sc>m</sc> Tris-HCl, 150 m<sc>m</sc> NaCl, 20m<sc>m</sc> imidazole, 0.1% w/v DDM (pH 7.5), and the bound protein waseluted with 20 m<sc>m</sc> Tris-HCl, 150 m<sc>m</sc> NaCl, 200m<sc>m</sc> imidazole, 0.1% w/v DDM (pH 7.5). A concentrated proteinsolution of 0.5 ml was applied to a Superdex 200 (HR) size-exclusion column(GE Healthcare) equilibrated in 20 m<sc>m</sc> Tris-HCl, 150 m<sc>m</sc>NaCl, 0.03% w/v DDM (pH 7.5). The purest fractions were pooled andconcentrated to 0.5 ml. To prevent artifactual thiol-disulfide exchangereactions from occurring during the thrombin cleavage, free thiols werealkylated with <italic>N</italic>-ethylmaleimide (Sigma)(<xref ref-type="bibr" rid="ref16">16</xref>). Purified protein wasincubated in the presence of 30 m<sc>m</sc><italic>N</italic>-ethylmaleimide for 1h at room temperature. After removal of the excess alkylating reagent, theprotein was cleaved using the thrombin Clean-Cleave kit according to themanufacturer's instructions (Sigma). The presence of the nDsbD-cDsbD mixeddisulfide was confirmed by Western blotting using two primary antibodies asfollows: 1) penta-His HRP-conjugated monoclonal antibody (Qiagen), and 2) goatantiserum raised against the cDsbD sequence of <italic>E. coli</italic> DsbD anddonkey anti-sheep alkaline phosphatase-conjugated antibody (Sigma), as primaryand secondary antibodies, respectively.</p><p><italic>Characterization of the nDsbD-cDsbD Mixed Disulfide Formed inVivo</italic>&#x02014;The covalent complex between nDsbD and cDsbD was N-terminallysequenced from protein samples in SDS-polyacrylamide gels that wereelectrophoretically transferred to a polyvinylidene difluoride membrane andstained with Coomassie Brilliant Blue. The protein bands were excised andsubjected to automated Edman sequencing using an Applied Biosystems 494AProcise protein sequencer.</p><p><italic>Simultaneous Overexpression of nDsbD andC464A-cDsbD</italic>&#x02014;Bacteria transformed with pDzn1 and pDzc5 were grownwith 100 &#x003bc;g ml<sup>-1</sup> ampicillin and 20 &#x003bc;g ml<sup>-1</sup>gentamycin to an <italic>A</italic><sub>600</sub> of 1.2 before addition of 1m<sc>m</sc> isopropyl &#x003b2;-<sc>d</sc>-thiogalactopyranoside. Afterfurther incubation for 4 h, the cells were harvested spheroplasted asdescribed (<xref ref-type="bibr" rid="ref17">17</xref>) omitting EDTA.Western blotting of the extracted periplasm for the detection of thenDsbD-cDsbD mixed disulfide complex was done using two primary antibodies asfollows: 1) <italic>Strep</italic>MAB-Classic HRP-conjugated monoclonal antibody (IBAGmbH), and 2) penta-His HRP-conjugated monoclonal antibody (Qiagen).</p><p><italic>Production and Purification of theC103A-nDsbD-<sup>15</sup>N-C464A-cDsbD Complex for NMR Studies</italic>&#x02014;Themixed disulfide complex was formed <italic>in vitro</italic> using C103A-nDsbD anduniformly <sup>15</sup>N-labeled C464A-cDsbD purified separately fromBL21(DE3) cells (Stratagene). For the production of C103A-nDsbD, cellstransformed with pDzn2 were grown at 30 &#x000b0;C with 20 &#x003bc;g ml<sup>-1</sup>gentamycin to an <italic>A</italic><sub>600</sub> of 1.5 before addition of 1m<sc>m</sc> isopropyl &#x003b2;-<sc>d</sc>-thiogalactopyranoside. Afterfurther incubation for 4 h at 37 &#x000b0;C the cells were harvested andspheroplasted as described(<xref ref-type="bibr" rid="ref17">17</xref>) omitting EDTA. Theperiplasmic fraction was applied to 5 ml of <italic>Strep</italic>-Tactin-Sepharose(IBA GmbH) equilibrated with 50 m<sc>m</sc> Tris-HCl, 150 m<sc>m</sc> NaCl(pH 7.5). The column was washed with 50 m<sc>m</sc> Tris-HCl, 1 <sc>m</sc>NaCl (pH 7.5), and the protein was eluted with 50 m<sc>m</sc> Tris-HCl, 150m<sc>m</sc> NaCl, 2.5 m<sc>m</sc> desthiobiotin (IBA GmbH) (pH 7.5)according to the manufacturer's instructions. Production and purification of<sup>15</sup>N-labeled C464A-cDsbD were done in the same way as for wild-typecDsbD, as described in previous work(<xref ref-type="bibr" rid="ref15">15</xref>).</p><p>The C103A-nDsbD-<sup>15</sup>N-C464A-cDsbD mixed disulfide complex wasprepared using a reported method(<xref ref-type="bibr" rid="ref12">12</xref>). First, C103A-nDsbD wasmixed with 10 m<sc>m</sc> dithiobisnitrobenzoic acid (Sigma) at 25 &#x000b0;Cfor 30 min. After removal of excess dithiobisnitrobenzoic acid, it was mixedwith equimolar <sup>15</sup>N-C464A-cDsbD and incubated as above. The reactionmixture was purified by two affinity chromatography steps, each specific toone of the domains. The mixture was applied to 3 ml of Fast FlowChelating-Sepharose (Amersham Biosciences) charged with Ni<sup>2+</sup>andpurified as described previously(<xref ref-type="bibr" rid="ref15">15</xref>). After removing theimidazole, the protein solution was applied to 3 ml of<italic>Strep</italic>-Tactin-Sepharose (IBA GmbH) and was purified as described abovefor C103A-nDsbD. The nDsbD-<sup>15</sup>N-cDsbD mixed-disulfide sample was ofhigh purity as assessed using SDS-PAGE (supplemental Fig. S1<italic>A</italic>), andits correct molecular weight was verified by electrospray ionization-massspectrometry (expected mass, 33,187 Da; observed mass, 33,185 Da).</p><p><italic>Production and Purification of the <sup>15</sup>N-labeled Wild Type andC464A-cDsbD</italic>&#x02014;<sup>15</sup>N-Labeled wild-type cDsbD and C464A-cDsbDwere used as control proteins for the pH titration of thenDsbD-<sup>15</sup>N-cDsbD mixed disulfide. Both proteins were produced andpurified as described previously(<xref ref-type="bibr" rid="ref15">15</xref>).</p><p><italic>pH Titration of the nDsbD-<sup>15</sup>N-cDsbD Mixed Disulfide UsingNMR Spectroscopy</italic>&#x02014;The <sup>1</sup>H<sup>N</sup> and <sup>15</sup>Nresonances of C464A-cDsbD as a separate domain and in thenDsbD-<sup>15</sup>N-cDsbD mixed disulfide were assigned using uniformly<sup>15</sup>N-labeled samples of 0.8 m<sc>m</sc> protein for the isolateddomains and 0.5 m<sc>m</sc> protein for the mixed disulfide, in 95%H<sub>2</sub>O, 5% D<sub>2</sub>O at pH 6.5. Assignments for C464A-cDsbD inthe isolated domain and in the nDsbD-<sup>15</sup>N-cDsbD complex wereobtained by comparison of three-dimensional <sup>15</sup>N-edited nuclearOverhauser effect spectroscopy-HSQC and total correlation spectroscopy-HSQCspectra with the previously assigned spectra of reduced wild-type cDsbD(<xref ref-type="bibr" rid="ref15">15</xref>).</p><p>NMR experiments for the determination of the p<italic>K<sub>a</sub></italic> valuesof Asp<sup>455</sup> in the active-site of cDsbD in thenDsbD-<sup>15</sup>N-cDsbD mixed disulfide were performed using 0.5m<sc>m</sc> of complex in 95% H<sub>2</sub>O, 5% D<sub>2</sub>O.Determination of the p<italic>K<sub>a</sub></italic> values of Asp<sup>455</sup> inthe active-site of <sup>15</sup>N-labeled wild-type cDsbD and C464A-cDsbD wasdone in the same way as a control experiment. In the case of the<sup>15</sup>N-labeled wild-type cDsbD, the sample was a &#x0223c;1:1 mixture ofoxidized and reduced protein allowing simultaneous measurement of thep<italic>K<sub>a</sub></italic> value for the two oxidation states. The pH ofsolutions was adjusted by using small volumes of 0.1-1 <sc>m</sc> HCl or0.1-1 <sc>m</sc> NaOH. The pH of the samples was measured before and aftereach experiment, and the average of the two measurements was used for dataanalysis. The pH values given are direct pH meter readings measured at roomtemperature. Two-dimensional <sup>1</sup>H-<sup>15</sup>N HSQC spectra werecollected at 313 K on a home-built 750-MHz NMR spectrometer, which iscontrolled with GE/Omega software and is equipped with a home-builttriple-resonance pulsed-field gradient probe-head. Sweep widths of 9345.79 Hzand 2500 were used in F<sub>2</sub> (<sup>1</sup>H) and F<sub>1</sub>(<sup>15</sup>N), respectively. 128 complex <sup>15</sup>N increments of 8,12, and 96 scans were collected with 1024 complex points in the acquisitiondimension for <sup>15</sup>N-labeled wild-type cDsbD, C464A-cDsbD, and thenDsbD-<sup>15</sup>N-cDsbD mixed disulfide complex, respectively. NMR datawere processed and visualized using NMRPipe, NMRDraw, and NMRView(<xref ref-type="bibr" rid="ref18">18</xref>,<xref ref-type="bibr" rid="ref19">19</xref>). Peak picking was carriedout using in-house software.</p><p><fig position="float" id="fig2"><label>FIGURE 2.</label><caption><p><bold>Western blots of purified full-length C464A thrombin-cleavable DsbDbefore and after thrombin cleavage.</bold> Penta-His HRP-conjugated antibody wasused in <italic>lanes 1-8</italic> and goat antiserum raised against cDsbD of <italic>E.coli</italic> DsbD was used in <italic>lanes 9-16. Lanes 1, 4, 9,</italic> and <italic>12</italic>show molecular mass markers (from the top these are 49, 38, 28, and 14 kDa);<italic>lanes 2</italic> and <italic>10</italic> show the negative control (nDsbD with noaffinity tag); <italic>lanes 3</italic> and <italic>11</italic> show the positive control(cDsbD bearing a C-terminal His<sub>6</sub> tag). C464A thrombin-cleavableDsbD is shown in <italic>lanes 5</italic> and <italic>13</italic> before alkylation of freethiols (<italic>A</italic>) and thrombin cleavage (<italic>T</italic>), in <italic>lanes 6</italic>and <italic>14</italic> without alkylation and after thrombin cleavage, in <italic>lanes7</italic> and <italic>15</italic> after alkylation and thrombin cleavage, and in<italic>lanes 8</italic> and <italic>16</italic> after alkylation and thrombin cleavage in thepresence of reductant (<italic>R</italic>). The cDsbD band can be seen at &#x0223c;14 kDain <italic>lanes 3</italic> and <italic>11</italic>, and in <italic>6-8</italic> and <italic>14-16</italic> in<italic>Box III</italic> (this construct runs as a diffuse double band on SDS-PAGEbecause its PelB signal sequence, which targets the protein to the periplasm,is cleaved inefficiently by the signal peptidase, leaving a large fraction ofthe protein uncleaved (confirmed by mass spectrometry and N-terminalsequencing)). The uncleaved C464A thrombin-cleavable DsbD band can be seen at&#x0223c;49 kDa (the actual mass of the protein is 60.8 kDa; a difference betweenthe two masses is common for membrane proteins) in <italic>lanes 5-8</italic> and<italic>13-16</italic> (<italic>box I</italic>) along with another band at &#x0223c;28 kDa that isa contaminant commonly seen after the purification of this protein. ThenDsbD-cDsbD mixed disulfide band can be seen at &#x0223c;32 kDa in <italic>lanes 6, 7,14,</italic> and <italic>15</italic> (<italic>box II</italic>) and it disappears in the presenceof reductant in <italic>lanes 8</italic> and <italic>16</italic>. 2-3 &#x003bc;g of total proteinwere loaded in each lane.</p></caption><graphic xlink:href="zbc0060963300002"/></fig></p><p><italic>pH Titration of [3-<sup>13</sup>C]Cysteine-labeled Wild Type andD455N-cDsbD</italic>&#x02014;<sup>1</sup>H-<sup>13</sup>C HSQC experiments for thedetermination of the p<italic>K<sub>a</sub></italic> value of Cys<sup>461</sup> at 313K were performed on solutions containing &#x0223c;1.5 m<sc>m</sc> of[3-<sup>13</sup>C]cysteine-labeled wild-type or D455N cDsbD in 99%D<sub>2</sub>O as described previously at 298 K(<xref ref-type="bibr" rid="ref15">15</xref>). Dithiothreitol was addedto maintain the proteins in the reduced state.</p><p><italic>Data Fitting</italic>&#x02014;p<italic>K<sub>a</sub></italic> values forAsp<sup>455</sup> were determined from <sup>1</sup>H<sup>N</sup> or<sup>15</sup>N chemical shifts measured as a function of pH.p<italic>K<sub>a</sub></italic> values for Cys<sup>461</sup> were determined from<sup>1</sup>H<sup>&#x003b2;</sup> or <sup>13</sup>C<sup>&#x003b2;</sup> chemicalshifts measured as a function of pH. The titration data were fitted to eitherone or two p<italic>K<sub>a</sub></italic> curves(<xref ref-type="bibr" rid="ref20">20</xref>) using in-house softwareas described previously (<xref ref-type="bibr" rid="ref15">15</xref>).The p<italic>K<sub>a</sub></italic> value for Asp<sup>455</sup> was determined fromthe pH dependence of five chemical shift values (Asp<sup>455</sup>/Glu<sup>4681</sup>H<sup>N</sup> and <sup>15</sup>N and Gln<sup>48815</sup>N<sup>&#x003b5;</sup>). The p<italic>K<sub>a</sub></italic> value forCys<sup>461</sup> was determined from the pH dependence of four to sixchemical shift values (Cys<sup>461</sup>/Cys<sup>464 1</sup>H<sup>&#x003b2;</sup>and <sup>13</sup>C<sup>&#x003b2;</sup>). Errors in the p<italic>K<sub>a</sub></italic>values were estimated as the standard deviation from the meanp<italic>K<sub>a</sub></italic> value. Details of the parameters obtained in each fitare listed in supplemental Tables S1 and S2.</p></sec><sec sec-type="results"><title>RESULTS</title><p><italic>In Vivo Studies of the Formation of an nDsbD-cDsbD Complex inFull-length DsbD</italic>&#x02014;We have used a thrombin-cleavable variant of DsbD(<xref ref-type="fig" rid="fig1">Fig. 1<italic>A</italic></xref>) to attemptto identify a mixed-disulfide complex of nDsbD and cDsbD <italic>in vivo</italic>.This construct expresses full-length DsbD in which nDsbD and cDsbD can each becleaved from the transmembrane domain by virtue of engineered thrombincleavage sites. The C464A mutation in cDsbD was introduced in an attempt totrap the nDsbD-cDsbD mixed-disulfide complex because Cys<sup>464</sup> isbelieved to be responsible for driving the cleavage of the interdomaindisulfide and the final transfer of reductant from cDsbD to nDsbD(<xref ref-type="bibr" rid="ref12">12</xref>). Thrombin-cleavable DsbDwas expressed, purified, incubated with <italic>N</italic>-ethylmaleimide to alkylateits free thiols, incubated with thrombin, and analyzed by SDS-PAGE and Westernblotting with antibodies against the His<sub>6</sub> tag and cDsbD; theresults of the Western blotting are shown in<xref ref-type="fig" rid="fig2">Fig. 2</xref>. It can be seen in<xref ref-type="fig" rid="fig2">Fig. 2</xref>, <italic>lanes 6, 7,14,</italic> and <italic>15,</italic> that a band of the expected molecular weight for annDsbD-cDsbD mixed disulfide (&#x0223c;32 kDa) appeared after thrombin cleavage ofthrombin-cleavable DsbD (<italic>box II</italic>). No band can be seen at thisposition before thrombin cleavage (<xref ref-type="fig" rid="fig2">Fig.2</xref>, <italic>lanes 5</italic> and <italic>13</italic>). The &#x0223c;32-kDa banddisappears in the presence of reductant(<xref ref-type="fig" rid="fig2">Fig. 2</xref>, <italic>lanes 8</italic> and<italic>16</italic>), confirming that it is a covalent complex containing a disulfidebond. The &#x0223c;32-kDa covalent complex from the SDS-PAGE band was N-terminallysequenced, and both the nDsbD ((M)LFDAPGRSQ) and cDsbD (GSGQTHLNFT) terminiwere detected. As seen in <xref ref-type="fig" rid="fig2">Fig.2</xref>, <italic>lanes 6</italic> and <italic>7</italic> or <italic>14</italic> and <italic>15,</italic>the band corresponding to the complex is present whether or not the freethiols of the protein were alkylated before thrombin cleavage. Incubation with<italic>N</italic>-ethylmaleimide, therefore demonstrates that this complex was formedbefore cleavage of the full-length protein. A band for the full-lengththrombin-cleavable DsbD can be seen (at &#x0223c;49 kDa) even after thrombincleavage (<xref ref-type="fig" rid="fig2">Fig. 2</xref>, <italic>lanes6-8</italic> and <italic>14-16, box I</italic>); this is attributed to inefficientthrombin cleavage because of the presence of the detergent DDM in the proteinsolutions. It is also likely that the presence of the protein in the detergentmicelle could reduce the accessibility of the protease cleavage sites to thethrombin (<xref ref-type="bibr" rid="ref21">21</xref>). Moreover, aC464A-cDsbD band can be seen (at &#x0223c;14 kDa) after thrombin cleavage even inthe absence of reductant (<xref ref-type="fig" rid="fig2">Fig.2</xref>, <italic>lanes 6, 7, 14,</italic> and <italic>15, box III</italic>). This isobserved because there are molecules in the protein sample in which thenDsbD-cDsbD mixed disulfide had not formed and for which the thrombin cleavageled to release of the two separate periplasmic domains (isolated nDsbD cannotbe seen in the Western blot because it is not His<sub>6</sub>-tagged).</p><p><fig position="float" id="fig3"><label>FIGURE 3.</label><caption><p><bold>Western blots of periplasmic extracts of <italic>E. coli</italic> expressingnDsbD with a streptavidin tag and C464A-cDsbD with a His<sub>6</sub> tag.</bold><italic>Strep</italic>MAB-Classic HRP-conjugated antibody was used in <italic>lanes1-4</italic> and penta-His HRP-conjugated antibody was used in <italic>lanes 5-8.Lanes 1</italic> and <italic>5</italic> show molecular mass markers; <italic>lanes 2</italic> and<italic>6</italic> show the negative control (nDsbD with no affinity tag); <italic>lanes3</italic> and <italic>7</italic> show positive controls (full-length DsbD with aC-terminal streptavidin tag and cDsbD with a C-terminal His<sub>6</sub> tag,respectively), and <italic>lanes 4</italic> and <italic>8</italic> show the periplasmicextract. The full-length DsbD band can be seen at &#x0223c;49 kDa in <italic>lane3</italic> along with a small amount of contaminant at &#x0223c;28 kDa (seeexplanation in <xref ref-type="fig" rid="fig2">Fig. 2</xref>). ThenDsbD band can be seen at &#x0223c;17 kDa in <italic>lane 4</italic> and the cDsbD bandcan be seen at &#x0223c;14 kDa (the diffuse double band is explained in<xref ref-type="fig" rid="fig2">Fig. 2</xref>) in <italic>lanes 7</italic> and<italic>8</italic> along with the band of its homodimer at &#x0223c;33 kDa. 15-20 &#x003bc;g oftotal protein were loaded in each lane.</p></caption><graphic xlink:href="zbc0060963300003"/></fig></p><p><italic>In Vivo Studies of Complex Formation between Isolated nDsbD andcDsbD</italic>&#x02014;To assess the role of tmDsbD in mediating the interactionbetween nDsbD and cDsbD, the two periplasmic domains of DsbD, nDsbD bearing aC-terminal streptavidin tag and a C464A variant of cDsbD bearing a C-terminalHis<sub>6</sub> tag, were overexpressed simultaneously as soluble proteinsexported to the periplasm. The C464A mutation in cDsbD was used for reasonsdescribed above. The periplasmic extract was analyzed by SDS-PAGE and Westernblotting with antibodies against the streptavidin tag, to detect nDsbD, andagainst a penta-histidine sequence, to detect cDsbD. The nDsbD-cDsbD mixeddisulfide is expected to migrate on SDS-PAGE between the 28- and 38-kDamolecular mass markers and to be detected by both antibodies(<xref ref-type="fig" rid="fig3">Fig. 3</xref>). No band correspondingto the nDsbD-cDsbD mixed disulfide was observed in<xref ref-type="fig" rid="fig3">Fig. 3</xref>, <italic>lanes 4</italic> and<italic>8</italic>. In <xref ref-type="fig" rid="fig3">Fig. 3</xref>, <italic>lane4,</italic> only the nDsbD band at &#x0223c;17 kDa is observed, and in <italic>lane 8</italic>the C464A-cDsbD band at &#x0223c;14 kDa and a band corresponding to its homodimerat &#x0223c;33 kDa (confirmed by Western blotting, not shown) are observed.</p><p>A possible explanation for the failure of the nDsbD-cDsbD mixed-disulfidecomplex to form <italic>in vivo</italic> is that the proteins were present in theincorrect oxidation states for disulfide bond formation to occur; interdomaindisulfide bond formation requires the presence of oxidized nDsbD and reducedC464A-cDsbD. NMR studies of periplasmically overexpressed nDsbD show that itis present predominantly in the oxidized form. cDsbD cannot form anintramolecular disulfide bond because it has a single cysteine and thehomodimer is observed as only a minor species(<xref ref-type="fig" rid="fig3">Fig. 3</xref>, <italic>lane 8</italic>). Forthese reasons, attack of the cDsbD cysteine thiol on the disulfide of nDsbD,as occurs in the physiological pathway, should have been possible. Wetherefore conclude that a complex between soluble nDsbD and cDsbD,co-expressed in the <italic>E. coli</italic> periplasm, does not form in the absenceof the transmembrane domain that usually connects the two domains in thefull-length protein.</p><p><italic>NMR Analysis of the nDsbD-<sup>15</sup>N-cDsbD Mixed-disulfideComplex</italic>&#x02014;A mixed-disulfide complex was produced using purifiedsingle-cysteine variants of nDsbD (C103A) and cDsbD (C464A) to ensure that thephysiologically relevant disulfide was formed(Cys<sup>461</sup>-SS-Cys<sup>109</sup>), to avoid any cleavage of thisdisulfide because of the presence of Cys<sup>464</sup> and to eliminate anycomplications during the p<italic>K<sub>a</sub></italic> determination ofAsp<sup>455</sup> caused by the titration of the Cys<sup>464</sup> orCys<sup>103</sup> thiols in the active site. NMR spectroscopy allowsmeasurement of the p<italic>K<sub>a</sub></italic> value of Asp<sup>455</sup> in theactive site of cDsbD when cDsbD is in close proximity to its periplasmicpartner nDsbD. For this purpose we used uniformly <sup>15</sup>N-labeledC464A-cDsbD covalently linked to unlabeled C103A-nDsbD, thus producing aC103A-nDsbD-<sup>15</sup>N-C464A-cDsbD covalent complex (subsequently referredto as nDsbD-<sup>15</sup>N-cDsbD) where only cDsbD gives NMR signals in the<sup>1</sup>H-<sup>15</sup>N HSQC spectrum but in which it is influenced bythe presence of nDsbD. In this way we were able to simplify the NMR spectrumof a relatively large (&#x0223c;32-kDa) protein complex and to focus on the domainof interest.</p><p>Previous studies of isolated cDsbD were carried out at 298 K. The<sup>1</sup>H-<sup>15</sup>N HSQC spectrum of the nDsbD-<sup>15</sup>N-cDsbDcomplex at 298 K is significantly broader, because of the higher molecularweight of the complex, than that of isolated cDsbD, and many of the expectedpeaks are not observed (supplemental Fig. S1, <italic>D</italic> and <italic>E</italic>). Asignificant improvement in the quality of the HSQC spectrum of the complex wasobserved at 313 K (supplemental Fig. S1<italic>F</italic>); at this temperature allexpected peaks from cDsbD are observed. Both nDsbD and cDsbD have relativelyhigh thermal stabilities and are completely folded and native at 313 K(supplemental Fig. S1<italic>B</italic>). The pH titration experiments described belowwere therefore performed at 313 K.</p><p><italic>pK<sub>a</sub> Determination for Asp<sup>455</sup> in thenDsbD-<sup>15</sup> N-cDsbD Complex</italic>&#x02014;We have monitored, between pH 4and pH 10, the <sup>15</sup>N and <sup>1</sup>H<sup>N</sup> chemical shifts ofthe backbone amides of Asp<sup>455</sup> and Glu<sup>468</sup> and the sidechain <sup>15</sup>N<sup>&#x003b5;</sup> of Gln<sup>488</sup> in HSQC spectra ofthe nDsbD-<sup>15</sup>N-cDsbD mixed-disulfide complex(<xref ref-type="fig" rid="fig4">Fig. 4<italic>A</italic></xref>). Theseshifts are all sensitive to titration of Asp<sup>455</sup> because of ahydrogen bond network involving Asp<sup>455</sup>, Glu<sup>468</sup>, andGln<sup>488</sup> (<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref11">11</xref>). We have shown previouslythat cDsbD is stable between pH 4 and 12(<xref ref-type="bibr" rid="ref15">15</xref>). <sup>1</sup>H NMRspectra of the complex collected between pH 4 and 10 demonstrate that nDsbD inthe complex is also stable over this pH range (supplemental Fig.S1<italic>C</italic>). Analysis of the pH dependence of the <sup>15</sup>N and<sup>1</sup>H<sup>N</sup> chemical shifts of Asp<sup>455</sup> andGlu<sup>468</sup> and of the side chain <sup>15</sup>N<sup>&#x003b5;</sup> ofGln<sup>488</sup> gave an average p<italic>K<sub>a</sub></italic> value of 8.5&#x000b1; 0.1 for Asp<sup>455</sup> (<xref ref-type="fig" rid="fig5">Fig. 5,<italic>A</italic>-<italic>C</italic></xref>). This p<italic>K<sub>a</sub></italic> value issignificantly higher than the values of 5.9 &#x000b1; 0.1 and 6.6 &#x000b1; 0.1obtained previously for Asp<sup>455</sup> in reduced and oxidized cDsbD(<xref ref-type="bibr" rid="ref15">15</xref>). Our previous study ofcDsbD was carried out at 298 K, whereas the spectra of the complex werecollected at 313 K. As a control, we have monitored the same chemical shiftsin uniformly <sup>15</sup>N-labeled wild-type cDsbD at 313 K. The experimentwas performed, as before (<xref ref-type="bibr" rid="ref15">15</xref>),in a mixed oxidation state sample, and we obtained a p<italic>K<sub>a</sub></italic>value of 6.5 &#x000b1; 0.1 in the reduced state and of 7.0 &#x000b1; 0.1 forAsp<sup>455</sup> in the oxidized state(<xref ref-type="fig" rid="fig5">Fig. 5,<italic>A</italic>-<italic>C</italic></xref>). These values are &#x0223c;0.5 pH units higherthan the values measured at 298 K but are nevertheless still significantlylower than the value of 8.5 measured for Asp<sup>455</sup> in thenDsbD-<sup>15</sup>N-cDsbD complex. To ensure that the difference in thep<italic>K<sub>a</sub></italic> values of Asp<sup>455</sup> between complexed anduncomplexed cDsbD is not an effect of the C464A mutation, we have alsoperformed the titration for uniformly <sup>15</sup>N-labeled C464A-cDsbD at313 K and obtained an average p<italic>K<sub>a</sub></italic> value of 7.4 &#x000b1;0.1 for Asp<sup>455</sup> (<xref ref-type="fig" rid="fig4">Fig.4<italic>B</italic></xref> and <xref ref-type="fig" rid="fig5">Fig. 5,<italic>A-C</italic></xref>). Therefore, it can be concluded that thep<italic>K<sub>a</sub></italic> value of Asp<sup>455</sup> is elevated by at least 1.1pH units when cDsbD forms a complex with nDsbD.</p><p><fig position="float" id="fig4"><label>FIGURE 4.</label><caption><p><bold>Overlay of two-dimensional <sup>1</sup>H-<sup>15</sup>N HSQC spectra ofthe nDsbD-<sup>15</sup>N-C464A-cDsbD complex (<italic>A</italic>) and<sup>15</sup>N-C464A-cDsbD collected at 750 MHz and 313 K for pH valuesranging from 4 to 10 (<italic>B</italic>).</bold> For thenDsbD-<sup>15</sup>N-C464A-cDsbD complex, spectra collected at pH 4.635(<italic>light gray</italic>), 5.09 (<italic>dark gray</italic>), 5.73 (<italic>black</italic>), 6.57(<italic>red</italic>), 7.165 (<italic>orange</italic>), 7.55 (<italic>yellow</italic>), 8.00(<italic>green</italic>), 8.43 (<italic>blue-green</italic>), 8.845 (<italic>cyan</italic>), 9.32(<italic>blue</italic>), and 9.755 (<italic>violet</italic>) are shown. For<sup>15</sup>N-C464A-cDsbD, spectra collected at pH 4.36 (<italic>lightgray</italic>), 4.895 (<italic>dark gray</italic>), 5.53 (<italic>black</italic>), 6.075(<italic>red</italic>), 6.61 (<italic>orange</italic>), 7.21 (<italic>yellow</italic>), 7.685(<italic>green</italic>), 8.155 (<italic>blue-green</italic>), 8.61 (<italic>cyan</italic>), 9.11(<italic>blue</italic>), and 9.86 (<italic>violet</italic>) are shown. The <italic>blacklines</italic> drawn in <italic>A</italic> and <italic>B</italic> trace the pH-dependent chemicalshift changes observed for Asp<sup>455</sup>.</p></caption><graphic xlink:href="zbc0060963300004"/></fig></p><p><fig position="float" id="fig5"><label>FIGURE 5.</label><caption><p><bold>Measurement of the p<italic>K<sub>a</sub></italic> value of the active-siteresidue Asp<sup>455</sup> from the pH dependence of the <sup>15</sup>Nchemical shift of Asp<sup>455</sup> (<italic>A</italic>), the <sup>15</sup>N chemicalshift of Glu<sup>468</sup> (<italic>B</italic>), and the<sup>15</sup>N</bold><sup>&#x003b5;</sup><bold>chemical shift of Gln<sup>488</sup>(<italic>C</italic>).</bold> Plots are shown for the nDsbD-C464A-cDsbD complex(&#x02022;), isolated C464A-cDsbD (&#x025a1;), and for oxidized (&#x025be;) andreduced (&#x025b5;) isolated wild-type cDsbD. The <italic>continuous lines</italic> showthe best fit to a single p<italic>K<sub>a</sub></italic> value or to twop<italic>K<sub>a</sub></italic> values for each dataset. The fitting procedure hasbeen described previously(<xref ref-type="bibr" rid="ref15">15</xref>); see supplemental TableS1 for a summary of the fitted parameters.</p></caption><graphic xlink:href="zbc0060963300005"/></fig></p><p><italic>pK<sub>a</sub> Determination for Cys<sup>461</sup> at 313K</italic>&#x02014;The p<italic>K<sub>a</sub></italic> value for Cys<sup>461</sup> wasmeasured for wild-type cDsbD and for the D455N variant of cDsbD at 313 K fordirect comparison with the p<italic>K<sub>a</sub></italic> values measured above forAsp<sup>455</sup> in the nDsbD-<sup>15</sup>N-cDsbD complex at 313 K. Analysisof the pH dependence of the <sup>13</sup>C<sup>&#x003b2;</sup> and<sup>1</sup>H<sup>&#x003b2;</sup> chemical shifts of Cys<sup>461</sup> andCys<sup>464</sup> in cDsbD gives p<italic>K<sub>a</sub></italic> values of 10.4&#x000b1; 0.1 and 9.2 &#x000b1; 0.2 for Cys<sup>461</sup> in wild-type and D455NcDsbD, respectively (supplemental Fig. S2 and supplemental Table S2). Thesevalues agree within experimental error with the values of 10.5 &#x000b1; 0.1and 9.3 &#x000b1; 0.05 reported previously at 298 K. Therefore, thep<italic>K<sub>a</sub></italic> value of Cys<sup>461</sup> does not show a temperaturedependence.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>It has long been known that DsbD functions by interaction between thecysteine pairs in its three domains, although how these interactions occurwithin this protein, in which one of the three domains is membrane-embedded,has remained elusive. In this study we have used both <italic>in vivo</italic> and<italic>in vitro</italic> approaches to understand how the interaction and reactionbetween the two soluble domains are controlled. We have demonstrated usingWestern blotting that a covalent nDsbD-cDsbD complex can be trapped <italic>invivo</italic> when full-length DsbD is overexpressed. This result proves that thenDsbD-cDsbD interaction, which has previously only been probed <italic>invitro</italic> (<xref ref-type="bibr" rid="ref12">12</xref>), isphysiologically relevant. No such complex was detected when the individualdomains, nDsbD and cDsbD, were co-expressed in the periplasm.</p><p>The fact that the nDsbD-cDsbD complex was not detectable in the absence ofthe linking tmDsbD has important implications for the function of themembrane-embedded domain. The latter is known to interact with, and acquirereductant from, cytoplasmic thioredoxin and so effectively performs thetransmembrane reductant transfer reaction(<xref ref-type="bibr" rid="ref22">22</xref>). In addition, it appearsto have an important function in ensuring the proximity and correctorientation of the two periplasmic domains. It should be noted that theinteraction interface identified in the nDsbD-cDsbD crystal structure is notvery extensive and involves a relatively small number of interactions(<xref ref-type="bibr" rid="ref12">12</xref>). This limited interfacemay result in a relatively low affinity interaction between nDsbD and cDsbD.Therefore, the transmembrane domain may be essential to ensure the high localconcentration of the domains that would be required for the formation of acomplex and subsequent electron transfer via the disulfide exchangereaction.</p><p>In isolated cDsbD, Cys<sup>461</sup>, which catalyzes reduction of theCys<sup>103</sup>-Cys<sup>109</sup> disulfide in nDsbD, has ap<italic>K<sub>a</sub></italic> value of 10.4 at 313 K; this elevated value makesCys<sup>461</sup> a poor nucleophile. The p<italic>K<sub>a</sub></italic> value ofCys<sup>461</sup> must therefore be lowered when it approaches nDsbD to makeit more reactive. The high p<italic>K<sub>a</sub></italic> value for Cys<sup>461</sup>results from its close proximity to Asp<sup>455</sup> and Glu<sup>468</sup> inthe active site. Here we have used the covalent nDsbD-<sup>15</sup>N-cDsbDcomplex to measure the p<italic>K<sub>a</sub></italic> value of Asp<sup>455</sup> incDsbD when it is in close contact with nDsbD. We found that thep<italic>K<sub>a</sub></italic> value of Asp<sup>455</sup> is elevated by at least 1.1pH units to a value of 8.5 in the complex at 313 K. At pH 7.0, the ratio ofdeprotonated (negatively charged) to protonated (uncharged) Asp<sup>455</sup>in the complex will be 0.03:1. In effect, the carboxyl side chain ofAsp<sup>455</sup> is fully protonated. This will have a similar effect as theD455N mutation that we have found previously leads to a 1.2 pH unit decreasein the p<italic>K<sub>a</sub></italic> value of Cys<sup>461</sup> (from 10.4 to 9.2 at313 K) (<xref ref-type="bibr" rid="ref15">15</xref>). Therefore, weconclude that when nDsbD and cDsbD form a complex, a reduction in thep<italic>K<sub>a</sub></italic> of Cys<sup>461</sup> by at least 1.2 pH units to avalue of &#x0223c;9.2 will take place. The concentration of the thiolate form ofCys<sup>461</sup> will increase &#x0223c;16-fold at physiological pH making thiscysteine a better nucleophile.</p><p>This experimental result is broadly consistent with previous electrostaticcalculations carried out using x-ray structures, which predictedp<italic>K<sub>a</sub></italic> values of 4.8 and 9.9 for Asp<sup>455</sup> in theisolated cDsbD and the nDsbD-cDsbD complex, respectively(<xref ref-type="bibr" rid="ref10">10</xref>). It should be noted thatsuch calculations are extremely sensitive to small differences in x-raystructures; the program PROPKA gives predicted p<italic>K<sub>a</sub></italic> valuesfor Asp<sup>455</sup> of 9.6, 7.0, and 7.7 using the three nDsbD-cDsbDmolecules in the asymmetric unit(<xref ref-type="bibr" rid="ref23">23</xref>). Ap<italic>K<sub>a</sub></italic> value of 5.4 is predicted by PROPKA forAsp<sup>455</sup> in isolated reduced cDsbD. The increase in the predictedp<italic>K<sub>a</sub></italic> value for Asp<sup>455</sup> in the complex arises froman increase in the desolvation of the side chain of Asp<sup>455</sup> and froman increased charge-charge contribution from Glu<sup>468</sup> as this residuebecomes more buried in the complex(<xref ref-type="bibr" rid="ref23">23</xref>).</p><p>The side chains of Cys<sup>461</sup> and Asp<sup>455</sup> are in closeproximity in the active site of cDsbD. These residues are homologous toCys<sup>32</sup> and Asp<sup>26</sup> in thioredoxin; microscopicp<italic>K<sub>a</sub></italic> values of 7.5 and 9.2 must be invoked to explain theirtitration behavior in thioredoxin(<xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref25">25</xref>). If Asp<sup>26</sup>titrates first with a p<italic>K<sub>a</sub></italic> of 7.5, then Cys<sup>32</sup> inthe same molecule will have a p<italic>K<sub>a</sub></italic> value of 9.2.Conversely, if Cys<sup>32</sup> titrates with a p<italic>K<sub>a</sub></italic> of7.5, then Asp<sup>26</sup> will have an elevated p<italic>K<sub>a</sub></italic> of9.2. In isolated and reduced cDsbD microscopic p<italic>K<sub>a</sub></italic> valuesare not relevant because the measured p<italic>K<sub>a</sub></italic> values of 6.5and 10.4 for Asp<sup>455</sup> and Cys<sup>461</sup>, respectively, at 313 Kdiffer so significantly (<xref ref-type="bibr" rid="ref15">15</xref>).However, when cDsbD comes into contact with nDsbD, and thep<italic>K<sub>a</sub></italic> value of Asp<sup>455</sup> is raised to 8.5,microscopic p<italic>K<sub>a</sub></italic> values may need to be considered. In thiscase, if Asp<sup>455</sup> titrates first with a p<italic>K<sub>a</sub></italic> of8.5, then Cys<sup>461</sup> in the same molecule will have ap<italic>K<sub>a</sub></italic> of &#x0223c;10.4. However, if Cys<sup>461</sup> titratesfirst it will have a p<italic>K<sub>a</sub></italic> of 8.5, and Asp<sup>455</sup>will have a p<italic>K<sub>a</sub></italic> of &#x0223c;10.4. In the latter case,Cys<sup>461</sup> is significantly more reactive than in isolated cDsbD(&#x0223c;80-fold increase in the concentration of the thiolate form ofCys<sup>461</sup>). This proposed lowering of the Cys<sup>461</sup>p<italic>K<sub>a</sub></italic> cannot be confirmed experimentally by NMR becausenDsbD and cDsbD do not form at stable high affinity complex in the absence ofa mixed disulfide involving Cys<sup>461</sup>.</p><p>The elevated p<italic>K<sub>a</sub></italic> value of 10.4 for Cys<sup>461</sup> inisolated cDsbD has the advantage of protecting cDsbD from nonspecificreoxidation, for example, by the powerful periplasmic oxidase DsbA. When cDsbDand nDsbD interact, the p<italic>K<sub>a</sub></italic> value of Cys<sup>461</sup> islowered leading to an increase in the nucleophilic character of this residue.Asp<sup>455</sup> is only able to exert this control over the reactivity ofCys<sup>461</sup> in cDsbD because it is buried and already has a relativelyhigh p<italic>K<sub>a</sub></italic> value (&#x0223c;6) in the isolated domain. Thus,modulation of active-site p<italic>K<sub>a</sub></italic> values resulting fromchanges in the environment of the active site is key to the specificity ofcDsbD.</p><p>Similar perturbations to p<italic>K<sub>a</sub></italic> values may occur in theactive sites of other thioredoxin-like oxidoreductases. A general acid/basecatalytic mechanism has been proposed for <italic>E. coli</italic> thioredoxin on thebasis of p<italic>K<sub>a</sub></italic> values measured for the isolated protein(<xref ref-type="bibr" rid="ref26">26</xref>). In the final step of themechanism, the deprotonated carboxyl group of Asp<sup>26</sup> (which is thestructural counterpart of Asp<sup>455</sup> in cDsbD) is proposed to abstracta proton from the thiol of Cys<sup>35</sup>, either directly or via a bridgingwater molecule (<xref ref-type="bibr" rid="ref27">27</xref>), and theresulting thiolate attacks the mixed disulfide to form the reduced substrateand oxidized thioredoxin. A similar role for the analogous Asp/Glu issuggested in other thiol:disulfide oxidoreductases(<xref ref-type="bibr" rid="ref26">26</xref>). Thep<italic>K<sub>a</sub></italic> value of 6.5 measured for Asp<sup>455</sup> inisolated cDsbD suggests it could play a similar role. However, the elevatedp<italic>K<sub>a</sub></italic> value of 8.5 for Asp<sup>455</sup> in the nDsbD-cDsbDcomplex makes this role unlikely. Other acidic groups in proximity to thethiol group of Cys<sup>464</sup>, such as Glu<sup>468</sup>, may play thisrole in cDsbD. An alternative mechanism for thioredoxin has been proposed inwhich the thiolate group in the substrate protein abstracts the proton fromCys<sup>35</sup> (<xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref29">29</xref>); this mechanism would alsodepend on the p<italic>K<sub>a</sub></italic> value of the substrate thiol in thecomplex. Our results highlight the importance of considering the effects ofprotein-protein interactions in physiological complexes on the properties ofactive-site residues rather than simply considering protein domains inisolation.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="PMC_1" content-type="local-data"><caption><title>[Supplemental Data]</title></caption><media mimetype="text" mime-subtype="html" xlink:href="M805963200_index.html"/><media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="M805963200_1.pdf"/></supplementary-material></sec></body><back><ref-list><ref id="ref1"><label>1</label><mixed-citation publication-type="journal">Kadokura, H., Katzen, F., and Beckwith, J. (<year>2003</year>)<source>Annu. Rev. Biochem.</source><volume>72</volume><fpage>111</fpage>-135<pub-id pub-id-type="pmid">12524212</pub-id></mixed-citation></ref><ref id="ref2"><label>2</label><mixed-citation publication-type="journal">Ito, K., and Inaba, K. (<year>2008</year>) <source>Curr. Opin.Struct. Biol.</source><volume>18</volume><fpage>450</fpage>-458<pub-id pub-id-type="pmid">18406599</pub-id></mixed-citation></ref><ref id="ref3"><label>3</label><mixed-citation publication-type="journal">Katzen, F., and Beckwith, J. (<year>2000</year>)<source>Cell</source><volume>103</volume><fpage>769</fpage>-779<pub-id pub-id-type="pmid">11114333</pub-id></mixed-citation></ref><ref id="d32e2441"><label>4</label><mixed-citation publication-type="journal" id="d32e2444">Gordon, E. H., Page, M. D., Willis, A. C., and Ferguson, S. J.(<year>2000</year>) <source>Mol. Microbiol.</source><volume>35</volume><fpage>1360</fpage>-1374<pub-id pub-id-type="pmid">10760137</pub-id></mixed-citation></ref><ref id="ref5"><label>5</label><mixed-citation publication-type="journal">Collet, J. F., Riemer, J., Bader, M. W., and Bardwell, J. C.(<year>2002</year>) <source>J. Biol. Chem.</source><volume>277</volume><fpage>26886</fpage>-26892<pub-id pub-id-type="pmid">12004064</pub-id></mixed-citation></ref><ref id="ref6"><label>6</label><mixed-citation publication-type="journal">Crooke, H., and Cole, J. (<year>1995</year>) <source>Mol.Microbiol.</source><volume>15</volume><fpage>1139</fpage>-1150<pub-id pub-id-type="pmid">7623667</pub-id></mixed-citation></ref><ref id="ref7"><label>7</label><mixed-citation publication-type="journal">Hodson, C. T., Lewin, A., Hederstedt, L., and Le Brun, N. E.(<year>2008</year>) <source>J. Bacteriol.</source><volume>190</volume><fpage>4697</fpage>-4705<pub-id pub-id-type="pmid">18456809</pub-id></mixed-citation></ref><ref id="ref8"><label>8</label><mixed-citation publication-type="journal">Goulding, C. W., Sawaya, M. R., Parseghian, A., Lim, V., Eisenberg,D., and Missiakas, D. (<year>2002</year>) <source>Biochemistry</source><volume>41</volume><fpage>6920</fpage>-6927<pub-id pub-id-type="pmid">12033924</pub-id></mixed-citation></ref><ref id="ref9"><label>9</label><mixed-citation publication-type="journal">Haebel, P. W., Goldstone, D., Katzen, F., Beckwith, J., andMetcalf, P. (<year>2002</year>) <source>EMBO J.</source><volume>21</volume><fpage>4774</fpage>-4784<pub-id pub-id-type="pmid">12234918</pub-id></mixed-citation></ref><ref id="ref10"><label>10</label><mixed-citation publication-type="journal">Stirnimann, C. U., Rozhkova, A., Grauschopf, U., Bockmann, R. A.,Glockshuber, R., Capitani, G., and Grutter, M. G. (<year>2006</year>)<source>J. Mol. Biol.</source><volume>358</volume><fpage>829</fpage>-845<pub-id pub-id-type="pmid">16545842</pub-id></mixed-citation></ref><ref id="ref11"><label>11</label><mixed-citation publication-type="journal">Kim, J. H., Kim, S. J., Jeong, D. G., Son, J. H., and Ryu, S. E.(<year>2003</year>) <source>FEBS Lett.</source><volume>543</volume><fpage>164</fpage>-169<pub-id pub-id-type="pmid">12753926</pub-id></mixed-citation></ref><ref id="ref12"><label>12</label><mixed-citation publication-type="journal">Rozhkova, A., Stirnimann, C. U., Frei, P., Grauschopf, U.,Brunisholz, R., Grutter, M. G., Capitani, G., and Glockshuber, R.(<year>2004</year>) <source>EMBO J.</source><volume>23</volume><fpage>1709</fpage>-1719<pub-id pub-id-type="pmid">15057279</pub-id></mixed-citation></ref><ref id="ref13"><label>13</label><mixed-citation publication-type="journal">Stirnimann, C. U., Rozhkova, A., Grauschopf, U., Grutter, M. G.,Glockshuber, R., and Capitani, G. (<year>2005</year>) <source>Structure(Lond.)</source><volume>13</volume><fpage>985</fpage>-993</mixed-citation></ref><ref id="ref14"><label>14</label><mixed-citation publication-type="journal">Stirnimann, C. U., Grutter, M. G., Glockshuber, R., and Capitani,G. (<year>2006</year>) <source>Cell. Mol. Life Sci.</source><volume>63</volume><fpage>1642</fpage>-1648<pub-id pub-id-type="pmid">16786221</pub-id></mixed-citation></ref><ref id="ref15"><label>15</label><mixed-citation publication-type="journal">Mavridou, D. A., Stevens, J. M., Ferguson, S. J., and Redfield, C.(<year>2007</year>) <source>J. Mol. Biol.</source><volume>370</volume><fpage>643</fpage>-658<pub-id pub-id-type="pmid">17544440</pub-id></mixed-citation></ref><ref id="ref16"><label>16</label><mixed-citation publication-type="journal">Katzen, F., and Beckwith, J. (<year>2003</year>) <source>Proc.Natl. Acad. Sci. U. S. A.</source><volume>100</volume><fpage>10471</fpage>-10476<pub-id pub-id-type="pmid">12925743</pub-id></mixed-citation></ref><ref id="ref17"><label>17</label><mixed-citation publication-type="other">Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman,J. G., Smith, J. A., and Struhl, K. (<year>2003</year>) <source>CurrentProtocols in Molecular Biology</source>, pp.<fpage>16.1</fpage>-16.8, John Wiley &#x00026; Sons, Inc., NewYork<pub-id pub-id-type="pmid">18265320</pub-id></mixed-citation></ref><ref id="ref18"><label>18</label><mixed-citation publication-type="journal">Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J.,and Bax, A. (<year>1995</year>) <source>J. Biomol. NMR</source><volume>6</volume><fpage>277</fpage>-293<pub-id pub-id-type="pmid">8520220</pub-id></mixed-citation></ref><ref id="ref19"><label>19</label><mixed-citation publication-type="journal">Johnson, B. A. (<year>2004</year>) <source>Methods Mol.Biol.</source><volume>278</volume><fpage>313</fpage>-352<pub-id pub-id-type="pmid">15318002</pub-id></mixed-citation></ref><ref id="ref20"><label>20</label><mixed-citation publication-type="journal">Shrager, R. I., Cohen, J. S., Heller, S. R., Sachs, D. H., andSchechter, A. N. (<year>1972</year>) <source>Biochemistry</source><volume>11</volume><fpage>541</fpage>-547<pub-id pub-id-type="pmid">5011963</pub-id></mixed-citation></ref><ref id="ref21"><label>21</label><mixed-citation publication-type="journal">Hiniker, A., Vertommen, D., Bardwell, J. C., and Collet, J. F.(<year>2006</year>) <source>J. Bacteriol.</source><volume>188</volume><fpage>7317</fpage>-7320<pub-id pub-id-type="pmid">17015672</pub-id></mixed-citation></ref><ref id="ref22"><label>22</label><mixed-citation publication-type="journal">Chung, J., Chen, T., and Missiakas, D. (<year>2000</year>)<source>Mol. Microbiol.</source><volume>35</volume><fpage>1099</fpage>-1109<pub-id pub-id-type="pmid">10712691</pub-id></mixed-citation></ref><ref id="ref23"><label>23</label><mixed-citation publication-type="journal">Li, H., Robertson, A. D., and Jensen, J. H. (<year>2005</year>)<source>Proteins</source><volume>61</volume><fpage>704</fpage>-721<pub-id pub-id-type="pmid">16231289</pub-id></mixed-citation></ref><ref id="ref24"><label>24</label><mixed-citation publication-type="journal">Chivers, P. T., Prehoda, K. E., Volkman, B. F., Kim, B. M.,Markley, J. L., and Raines, R. T. (<year>1997</year>)<source>Biochemistry</source><volume>36</volume><fpage>14985</fpage>-14991<pub-id pub-id-type="pmid">9398223</pub-id></mixed-citation></ref><ref id="ref25"><label>25</label><mixed-citation publication-type="journal">Jeng, M. F., and Dyson, H. J. (<year>1996</year>)<source>Biochemistry</source><volume>35</volume><fpage>1</fpage>-6<pub-id pub-id-type="pmid">8555161</pub-id></mixed-citation></ref><ref id="ref26"><label>26</label><mixed-citation publication-type="journal">Chivers, P. T., and Raines, R. T. (<year>1997</year>)<source>Biochemistry</source><volume>36</volume><fpage>15810</fpage>-15816<pub-id pub-id-type="pmid">9398311</pub-id></mixed-citation></ref><ref id="ref27"><label>27</label><mixed-citation publication-type="journal">Menchise, V., Corbier, C., Didierjean, C., Saviano, M., Benedetti,E., Jacquot, J. P., and Aubry, A. (<year>2001</year>) <source>Biochem.J.</source><volume>359</volume><fpage>65</fpage>-75<pub-id pub-id-type="pmid">11563970</pub-id></mixed-citation></ref><ref id="ref28"><label>28</label><mixed-citation publication-type="journal">Jeng, M. F., Holmgren, A., and Dyson, H. J. (<year>1995</year>)<source>Biochemistry</source><volume>34</volume><fpage>10101</fpage>-10105<pub-id pub-id-type="pmid">7640264</pub-id></mixed-citation></ref><ref id="ref29"><label>29</label><mixed-citation publication-type="journal">Carvalho, A. T. P., Swart, M., van Stralen, J. N. P., Fernandes, P.A., Ramos, M. J., and Bickelhaupt, F. M. (<year>2008</year>) <source>J.Phys. Chem. B</source><volume>112</volume><fpage>2511</fpage>-2523<pub-id pub-id-type="pmid">18237164</pub-id></mixed-citation></ref></ref-list><fn-group><fn id="fn7"><label>6</label><p>The abbreviations used are: BisTris,2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol; DDM,<italic>n</italic>-dodecyl &#x003b2;-<sc>d</sc>-maltoside; HRP, horseradish peroxidase;HSQC, heteronuclear single quantum coherence.</p></fn></fn-group></back></article>